Panthera Biopartners
Andy Broomhead is the IT Director of Panthera Biopartners, joining in September 2022. With over 17 years of IT leadership experience, Andy has played a key role in driving digital transformation and aligning technology with business objectives. He leads the eSource implementation project, which will revolutionise the business by modernising clinical trial processes and enhancing data management. His leadership has resulted in substantial improvements in operational efficiency and revenue growth. Notably, Andy led the design, development, and implementation of the bespoke Digital Patient Pathway, significantly enhancing patient engagement and recruitment whilst reducing the cost of doing so.
Before joining Panthera, Andy held a senior management role at Clogau Gold of Wales, where he oversaw IT systems and infrastructure across multiple sites. He spearheaded the design and deployment of custom technology solutions, including a £20M+ annual e-commerce platform, while also driving advancements in cybersecurity and operational efficiency within the supply chain. His efforts contributed to optimising business operations and improving overall performance.
Andy holds an MBA from the University of Bradford and a First-Class BSc (Hons) in Computing from the University of Wales. His combination of academic excellence and extensive leadership experience has allowed him to seamlessly integrate technical expertise with strategic initiatives, ensuring the delivery of innovative technology solutions that drive business growth and strengthen IT governance.
Panthera Biopartners
1 followers
Panthera Biopartners, established in 2019, is a leading UK-based Site Management Organisation (SMO) specialising in patient recruitment and the execution of clinical trials across various therapeutic areas. Founded by Dr Ian Smith, the originator of Synexus, and Professor John Lyon, a former global executive at Covance, Panthera has rapidly expanded its network to include dedicated clinical trial sites in major UK cities such as Glasgow, London, Manchester, Preston, Sheffield and York The organisation's mission is to enhance healthcare accessibility by conducting clinical research that integrates diverse insights and expertise. Panthera is committed to maintaining rigorous ethical standards and contributing to medical advancements that positively impact health and well-being. Panthera's management team comprises experienced professionals with extensive knowledge in conducting clinical trials across multiple therapy areas and countries. Key figures include Dr Ian Smith (Co-Founder, Director, and Chief Medical Officer), Stuart Young (Chief Executive Officer), and Chris Dodd (Chief Commercial Officer). In October 2024, Panthera became the first UK clinical trial site organisation to join Parexel’s Site Alliance Vaccine Network, a global consortium of high-performing clinical trial sites. This collaboration underscores Panthera's exceptional performance in patient recruitment and its strong partnership with Parexel. Panthera's dedication to innovation and excellence was recognised in October 2023 when it was named Pharma Research Centre of the Year at the Pharma Industry Awards UK. The award highlighted Panthera's innovative SMO model, which emphasises rapid start-up times, access to a vast pool of prequalified patients, and the digitisation of patient engagement processes.